BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27913490)

  • 1. Heparin-induced thrombocytopenia: research and clinical updates.
    Onwuemene O; Arepally GM
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):262-268. PubMed ID: 27913490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia.
    Lee GM; Arepally GM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():668-74. PubMed ID: 24319250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HITlights: a career perspective on heparin-induced thrombocytopenia.
    Warkentin TE
    Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.
    Kasthuri RS; Glover SL; Jonas W; McEachron T; Pawlinski R; Arepally GM; Key NS; Mackman N
    Blood; 2012 May; 119(22):5285-93. PubMed ID: 22394597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia.
    Arepally GM
    Blood; 2017 May; 129(21):2864-2872. PubMed ID: 28416511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
    Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
    J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician.
    Hess CN; Becker RC; Alexander JH; Lopes RD
    J Thromb Thrombolysis; 2012 Nov; 34(4):552-61. PubMed ID: 22843169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia.
    Arepally GM; Ortel TL
    Annu Rev Med; 2010; 61():77-90. PubMed ID: 20059332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-induced thrombocytopenia].
    Thiele T; Althaus K; Greinacher A
    Internist (Berl); 2010 Sep; 51(9):1127-32, 1134-5. PubMed ID: 20694716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Autoimmun Rev; 2002 May; 1(3):125-32. PubMed ID: 12849005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on heparin-induced thrombocytopenia: diagnosis and management.
    Bakchoul T
    Expert Opin Drug Saf; 2016 Jun; 15(6):787-97. PubMed ID: 26966871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
    Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
    Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.
    Shih AW; Sheppard JI; Warkentin TE
    Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
    Matsuo T; Wanaka K; Asada R
    Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.